Imunon
IMNN
19 hedge funds and large institutions have $1.63M invested in Imunon in 2026 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
2.33% more ownership
Funds ownership: 14.07% → 16.4% (+2.3%)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
5% less funds holding
Funds holding: 20 → 19 (-1)
8% less capital invested
Capital invested by funds: $1.76M → $1.63M (-$136K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$268K |
| 2 |
HF
HRT Financial
New York
|
+$39.7K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$39.5K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.98K |
| 5 |
Morgan Stanley
New York
|
+$234 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
-$224K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$3.37K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$316 |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$103 |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$10 |
IMNN Hedge Fund Activity: Q1 2026 in Review
19 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q1 2026, worth a combined $1.63M — down 7.7% from $1.76M a quarter earlier.
Fund positioning in IMNN was balanced in Q1 2026: 3 funds opened new positions, 3 closed out, 6 added to existing stakes and 3 trimmed.
The largest buyer was Armistice Capital, adding an estimated $268K. The largest seller was DRW Securities, exiting entirely with an estimated $224K sold.
- 19 institutional investors held Imunon (IMNN) as of Q1 2026, down from 20 in Q4 2025.
- Funds reported $1.63M of Imunon stock for Q1 2026, down 7.7% quarter-over-quarter.
- 3 funds opened new Imunon positions in Q1 2026 and 3 closed out, a net change of 0 holders.
- The largest Imunon buyer in Q1 2026 was Armistice Capital, an estimated $268K added.
- The largest Imunon seller in Q1 2026 was DRW Securities, an estimated $224K sold.
Based on aggregated 13F filings for Q1 2026.